Roger Williams

Title: Roger Williams - Innovator in Phosphoinositide Research

Introduction

Roger Williams is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of biochemistry, particularly in the study of phosphoinositide 3-kinases (PI3K). His work has implications for understanding various cellular processes and potential therapeutic applications.

Latest Patents

Roger Williams holds a patent related to PI3K crystals, polypeptide muteins, polypeptide fragments, and antibodies. The patent also covers nucleic acids coding for these polypeptides, methods of modifying PI3Kγ activity, and methods of modulating PI3Kγ activity. This invention includes polypeptides and methods related to phospholipid binding, lipid kinase activity, and modulating Ras activity in activating PI3Kγ. It also addresses the binding of PI3Kγ to cell membranes and modulating protein-protein interactions with PI3Kγ. He has 1 patent to his name.

Career Highlights

Throughout his career, Roger has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Warner-Lambert Company and Onyx Pharmaceuticals, Inc. His experience in these organizations has contributed to his expertise in the field.

Collaborations

Roger has collaborated with esteemed colleagues, including Christian Ried and Edward H. Walker. These partnerships have furthered his research and innovation in the biochemistry domain.

Conclusion

Roger Williams is a distinguished inventor whose work on phosphoinositide 3-kinases has advanced our understanding of cellular mechanisms. His contributions continue to influence the field of biochemistry and hold promise for future therapeutic developments.